Funded startups/ASCENDIA PHARMACEUTICALS, INC.
AP

ASCENDIA PHARMACEUTICALS, INC.

SEC filing
Other Health Care · North Brunswick, NJ
Form D on EDGAR
Amount raised$4.1Msold at filing
Total offering$4.1M
Investors in the raise3count reported to the SEC
FiledJul 24, 2026first sale Jun 26, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Jingjun HuangDirector
Theron OdlaugDirector
Michael BogdaDirector
James GaleDirector
Robert BloderDirector
Shoufeng LiDirector

Executive officers, directors and promoters as listed on the Form D.

Filing history

FormFiledAmount soldOffering
DJul 24, 2026$4.1M$4.1MEDGAR
DJun 4, 2025$2.5M$2.5MEDGAR
DOct 11, 2024$2.5M$2.5MEDGAR